Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30018472HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043783HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043784HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043785HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043786HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043787HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043788HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043789HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043790HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043791HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TCGA Plot Options
Drug Information
GeneTOP2A
DrugBank IDDB00385
Drug NameValrubicin
Target IDBE0000742
UniProt IDP11388
Regulation Typeinhibitor
PubMed IDs11752352; 16019763
CitationsChen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Perabo FG, Muller SC: New agents in intravesical chemotherapy of superficial bladder cancer. Scand J Urol Nephrol. 2005;39(2):108-16.
GroupsApproved
Direct ClassificationAnthracyclines
SMILES[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)COC(=O)CCCC)O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1
Pathways
PharmGKBPA164748616
ChEMBLCHEMBL1096885